Previous 10 | Next 10 |
SWK Holdings to Participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6" PR Newswire DALLAS , Sept. 7, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finan...
SWK Holdings ( NASDAQ: SWKH ) promotes Managing Director Jody Staggs to the position of President, effective September 1, 2022. He will also serve as interim Chief Executive Officer, effective September 30, 2022. Winston Black, Chairman and CEO, will le...
SWK Holdings Announces Leadership Transition PR Newswire Jody Staggs appointed as President and Interim CEO CEO Winston Black will assist in an interim consulting role after successfully establishing SWK Holdings as a leading life science focused specia...
SWK Holdings Corporation (SWKH) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors Winston Black - Chairman and CEO Conference Call Participants Kyle Bauser - Lake Street Capital Mar...
SWK Holdings press release ( NASDAQ: SWKH ): Q2 GAAP EPS of $0.04 misses by $0.16 . Revenue of $6.94M (-68.9% Y/Y) misses by $1.76M . For further details see: SWK Holdings GAAP EPS of $0.04 misses by $0.16, revenue of $6.94M misses by $1.76M
SWK Holdings Corporation Announces Financial Results for Second Quarter 2022 PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET Corporate Highlights Celebrated 10 th anniversary as a...
SWK Holdings Corporation to Report Second Quarter 2022 Financial Results PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022 , at 10:00 a.m. ET DALLAS , Aug. 9, 2022 /PRNewswire/ -- SWK Holdings...
Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsour...
Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo PR Newswire BOONTON, N.J. ...
SWK Holdings Corporation Marks 10th Anniversary, Celebrating Growth and Progress PR Newswire Since 2012, SWK Holdings has completed financings with 46 life sciences companies, deploying $650 million of capital Second Quarter 2022 Financial Results to be Ann...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...